8-K - Immunovant, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

shall not be incorporated by reference in any filing with the U.S. Securities and Exchange Commission, or the SEC, made by the Company, whether made before or a

Financial Results

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release, dated February 6, 2026. 104 Cover Page Interactive Data File (embe

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1